Antibiotic Use Reductions May Decrease Clostridium difficile: FDA warning on fluoroquinolones, IDSA says limit therapy for VAP

    loading  Checking for direct PDF access through Ovid

Abstract

Two recent developments limiting antibiotic use could have a secondary benefit of reducing Clostridium difficile infections, which have been the bane of infection preventionists since emerging in a highly virulent strain some 15 years ago.

Related Topics

    loading  Loading Related Articles